Pharma Focus Asia

Advancing TB Drug Regimen Development Through Innovative Quantitative Translational Pharmacology Methods and Approaches

Authors: Debra Hannaa, Klaus Romeroa, Marco Schitoa


The development of novel TB multi-drug regimens that are more efficacious and of shorter induration requires a robust drug development pipeline. Advances in quantitative modeling and simulation can be used to maximize the utility of patient-level data from prior and contemporary clinical trials, thus optimizing study design for anti-TB regimens In this perspective article, we highlight work from seven project teams developing first-in-class translational and quantitative methodologies that aim to inform drug development decision-making dose selection, trial design and safety assessments, to achieve shorter and safer therapies for patients in need. These tools offer the opportunity to evaluate multiple hypotheses and provide a means to identify, quantify, and understand relevant sources of variability, to optimize translation and clinical trial design. When incorporated into the broader regulatory sciences framework, these efforts have the potential to transform the development paradigm for TB combination development, as well as other areas of global health.


Tuberculosis (TB); modeling; simulation; pharmacokinetic/pharmacodynamics (PK/PD); drug development; translational science

Citation: Debra Hannaa, Klaus Romeroa, Marco Schitoa Advancing TB Drug Regimen Development Through Innovative Quantitative Translational Pharmacology Methods and Approaches

Received: 7 October 2016, Accepted: 11 October 2016, Available online: 24 October 2016

Copyright: © 2016 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

The Critical Path to TB Drug Regimens program is supported by the Bill & Melinda Gates Foundation. The CPTR program would like to thank and acknowledge all of our collaborators including our partners at Baylor University, Certera, Colorado State University, University of California San Francisco and the University of Florida.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopNitrosamine Advance Workshop 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024